GGrantIndex
Sort

15,440 grants matching organoids

Developing human gonad organoids to promote germ cell differentiation

$205,000
Michael Buszczak · Ut Southwestern Medical Center · R21 · FY2022 · HD

Tissue and Pathology Core

$204,963
Deborah Dillon · Dana-Farber Cancer Inst · P01 · FY2020 · CA

Tissue and Pathology Core

$204,963
Deborah Dillon · Dana-Farber Cancer Inst · P01 · FY2021 · CA

(PQ5) Assessing the contribution of mitochondrial heterogeneity to gliomagenesis using single cell approaches

$204,885
Vivian Gama · Vanderbilt University · R21 · FY2019 · CA

Microphysiological System for the Human Hippocampal Dentate Gyrus-CA3 Circuit

$204,688
David W Nauen · Johns Hopkins University · R21 · FY2021 · NS

New ACE2 activator and its prodrug as novel therapeutic reagents for inflammatory pulmonary diseases

$204,688
Hongpeng Jia · Johns Hopkins University · R21 · FY2021 · AI

Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles

$204,607
Kenneth W Witwer · Johns Hopkins University · R21 · FY2018 · MH

Cell & Tissue Models

$204,579
Walter E Finkbeiner · University Of California, San Francisco · P30 · FY2015 · DK

Bioinformatics Core

$204,518
Gabor T Marth · University Of Utah · U54 · FY2024 · CA

Tissue and Pathology Core

$204,515
Deborah Dillon · Dana-Farber Cancer Inst · P01 · FY2024 · CA

Exploiting the Salivary Arsenal to Inhibit Diarrheal Disease

$204,375
Esther S. Bullitt · Boston University Medical Campus · R21 · FY2022 · AI

Transcriptional regulators of iris muscle cell development

$204,308
Timothy A. Blenkinsop · Icahn School Of Medicine At Mount Sinai · R21 · FY2021 · EY

Gene regulatory networks influencing neuron-microglia interactions in fetal brain development.

$204,282
Claudia Z Han · Washington University · R00 · FY2025 · MH

Application of Mucolytic Therapy in Patient-Derived Models of Pseudomyxoma Peritonei

$204,233
Mohammad Haroon Asif Choudry · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · CA

Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax

$204,181
Dean G Tang · Roswell Park Cancer Institute Corp · R21 · FY2020 · CA

CANCAN - Harvard

$204,036
Norbert Perrimon · Harvard Medical School · OT2 · FY2022 · CA

Mechanisms and biomarkers in aberrant paligenosis-induced stomach tumorigenesis

$204,000
Jason C Mills · Baylor College Of Medicine · R01 · FY2021 · CA

Extracellular Matrix Regulation of Airway Epithelial Homeostasis

$203,974
Daniel J Weiss · University Of Vermont & St Agric College · R21 · FY2024 · HL

Generation of multilineage adrenal gland organoids using human pluripotent stem cells

$203,824
Nadja Zeltner · University Of Georgia · R21 · FY2021 · HD

Utilizing Human Brain Organoids to Model the Differential Effects of SCN8A Mutation on Cortex and Hippocampus

$203,472
Ranmal A Samarasinghe · University Of California Los Angeles · K08 · FY2022 · NS

Utilizing Human Brain Organoids to Model the Differential Effects of SCN8A Mutation on Cortex and Hippocampus

$203,472
Ranmal A Samarasinghe · University Of California Los Angeles · K08 · FY2021 · NS

The role of senescence in severe COVID-19

$203,125
Tobias D. Raabe · University Of Pennsylvania · R21 · FY2025 · AI

Unraveling mechanisms of genome regulation to understand and improve human health

$203,089
Justin Lee Cotney · University Of Connecticut Sch Of Med/Dnt · R35 · FY2023 · GM

Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer

$203,026
Philip M Spanheimer · Univ Of North Carolina Chapel Hill · K08 · FY2024 · CA

Repurposing RET Inhibitors for Endocrine Resistant Breast Cancer

$203,026
Philip M Spanheimer · Univ Of North Carolina Chapel Hill · K08 · FY2025 · CA